Navigation Links
MSU investigates drug to halt Parkinson's progression
Date:7/29/2011

GRAND RAPIDS, Mich. Researchers from Michigan State University's College of Human Medicine, Van Andel Research Institute and the Translational Genomics Research Institute are investigating a drug that has the potential to not only alleviate Parkinson's symptoms but also halt the disease's progression.

A $400,000 grant from the Michael J. Fox Foundation for Parkinson's Research part of $2.4 million in funding the foundation awarded this week to institutions nationwide will fund the research project.

Researchers are focusing on the drug Fasudil, which is currently approved in Japan to improve blood flow to the brain in stroke victims and has shown similar positive outcomes in U.S. clinical trials.

In 2009, investigators from the Translational Genomics Research Institute in Arizona and Arizona State University reported that a form of Fasudil had the potential to help improve learning and memory and reduce the risk of Alzheimer's disease. Van Andel researchers also recently discovered the potential of the drug in Parkinson's when they were testing various drugs that reduce the toxicity caused by a defective PARK1 gene, a gene implicated in Parkinson's disease.

"The potential of this drug is exciting not only because it could halt disease progression where other treatments only provide symptomatic relief but also because of how quickly it could be made available to patients," said Jeffrey P. MacKeigan, head of Van Andel's Laboratory of Systems Biology and co-investigator on the project with Caryl E. Sortwell of MSU's College of Human Medicine.

"Fasudil has a very favorable safety profile in humans and already is available in Japan as an oral tablet, so we could be seeing clinical trials within two to three years," MacKeigan added.

The development of new drugs is expensive and time-consuming, said Kuldip Dave, associate director of research programs at MJFF.

"In fall 2010, MJFF launched our i
'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Long Island Press Investigates Big Tobacco's Lobby to Kill Indian Cigarette Trade
2. Food Safety Law Firm Investigates Major Outbreak of E. coli Linked To Lettuce
3. Thesis investigates characteristics of society using sports activities as research tool
4. UI study investigates variability in mens recall of sexual cues
5. BUSM investigates cellular mechanisms leading to immune response in airway epithelium
6. New genomics research investigates metastatic childhood cancers
7. Herpes Drug Might Also Slow HIV Progression
8. Targeting the blood-brain barrier may delay progression of Alzheimers disease
9. Statins may slow progression of multiple sclerosis, new study finds
10. Statins May Slow Progression of Multiple Sclerosis, New Study Finds
11. Exercise may slow progression of ALS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... National Physical Fitness and Sports Month , ... U.S. Department of Health and Human Services (HHS), designates ... Sports Month. It is dedicated to raising public ... Throughout the month of May, Americans are challenged ... The HHS details the benefits of regular daily and ...
(Date:5/6/2015)... May 06, 2015 Hope For The ... Annual Casino Night at the New York Athletic Club ... benefit Hope For The Warriors®, a national nonprofit dedicated ... unit, and restoring hope for our service members and ... $38K to support local and nationwide military families. The ...
(Date:5/6/2015)... 06, 2015 Qualidigm , ... has hired healthcare executive Ann Olson, RN, BSN, ... will lead Qualidigm’s growing home healthcare services and ... improve the quality, safety, and cost-effectiveness of healthcare ... from Interim HealthCare of North Haven, Inc., a ...
(Date:5/6/2015)... Raleigh, NC (PRWEB) May 06, 2015 ... pembrolizumab recently reported what they are calling “unprecedented” tumor ... an article on the new research. Click here ... oncologists gave pembrolizumab to 25 mesothelioma patients between March ... AACR meeting in April. , “Pembrolizumab… provides robust antitumor ...
(Date:5/6/2015)... Stout Industries is owned and operated ... Austin, Texas fire departments. Stout Industries recently developed Fire-ground ... components to these fire safety devices. The departure lights ... is turned on. They light the area within 50 feet ... on the roof, preventing leg and ankle injuries. In ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 2Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 3Health News:4th Annual Casino Night Draws Support for Military Families in New York City Region 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:Researchers Say “Unprecedented” Mesothelioma Response Possible with Skin Cancer Drug, According to Surviving Mesothelioma 2Health News:Kickstarter for FIRE Lights, the New Fire Safety Devices 2
... , , NASHVILLE, Tenn., ... care market intelligence, reports that while commercial pharmacy benefit ... 2008 and January 2009, commercial pharmacy benefit enrollment in ... a two percent decline over the same time period. ...
... , FORT LAUDERDALE, Fla., Aug. ... ), a leading provider of convenient at-home diet, fitness and ... Panel has granted the Company,s request for continued listing on ... subject to the condition that, on or before December 29, ...
... - Growing Traction in Specialty Tissue Business Producing Increased, ... ... Neovasc Reducer(TM) Commercialization Process on Track -, TSX Venture Exchange: NVC, ... financial results for the three and six months ended June 30, 2009. , "During ...
... , , SOMERSET, N.J., Aug. 19 ... with Cancer Care (R), it will try to break the Guinness World ... played simultaneously for charity. Cancer C are is a ... by cancer. , , Starting today at 11 a.m. ...
... ... ... 2009 -- The contributions of voluntary plasma donors and the issue of ... June when they proclaimed August "Plasma Protein Therapies Month" in the Lone Star State. ...
... /PRNewswire-Asia/ -- Sinovac Biotech Ltd.,(NYSE Amex: SVA ), a leading ... for the three-month and six-,month periods ended June 30, 2009. , , ... quarter increased 21% to $20.0 million, -- Sales for ... Operating income for the quarter rose 52% to $10.7 million, ...
Cached Medicine News:Health News:Miami-Area Experienced Fewer Fluctuations in Pharmacy Benefit Enrollment Than Other Florida Markets 2Health News:eDiets.com(R) Granted Continued Listing by NASDAQ Panel 2Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 2Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 3Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 4Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 5Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 6Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 7Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 8Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 9Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 10Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 11Health News:Neovasc Inc. Reports Second Quarter 2009 Financial Results 12Health News:CancerCare(R) and the Tic Tac(R) Brand Attempt To Set a World Record in Times Square 2Health News:CancerCare(R) and the Tic Tac(R) Brand Attempt To Set a World Record in Times Square 3Health News:Plasma protein Therapies Association Focuses Attention on Donors and Facilities 2Health News:Plasma protein Therapies Association Focuses Attention on Donors and Facilities 3Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 2Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 3Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 4Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 5Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 6Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 7Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 8Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 9Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 10Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 11Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 12Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 13Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 14
(Date:5/6/2015)... 6, 2015 Woodford Patient ... Wellcome Trust and the Bill & Melinda Gates ... Kymab, a leading monoclonal antibody biopharmaceutical company, announced ... US$50 million to complete a US$90 million Series ... by Woodford Patient Capital Trust plc (LSE:WPCT,"Woodford") and ...
(Date:5/5/2015)... , LONDON and NEW YORK ... on ASEAN respiratory devices with a detailed analysis of:   ... diagnostic   - Markets such as Indonesia ... Philippines , Singapore , Thailand ... Australia , New Zealand and ...
(Date:5/5/2015)... -- CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused ... of infectious diseases, announced that it will report first ... Milby , Chief Executive Officer of CorMedix, will host ... 9:00 a.m. EDT.  In order to ... 1-201-689-8031 (outside the U.S.). All participants who dial in ...
Breaking Medicine Technology:Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 2Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 3Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 4Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 5CorMedix, Inc. to Report First Quarter Financial Results on May 8, 2015 2
... Bright and playful, ... is perfect for girls ... fun.Trendy shapes, colorful accents ... flare to this exciting ...
... new collection captures the whimsy, charm and ... Rowley. Each design is inspired by Cynthia ... design teams from the Kenmark Group and ... initial launch features eight optical and four ...
... Managed care is something that almost ... Eyewear answers these needs with VALUE - ... quality and design. Jobson Research shows that ... for managed care product., ,National offers an ...
... Esprit is an internationally known ... youthful image. The ophthalmic collection offers ... originality and creativity in titanium, metal ... line features unique styling with trendy ...
Medicine Products: